United Therapeutics CorporationUTHRNASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+18.0%
5Y CAGR+16.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
+18.0%/yr
vs +4.4%/yr prior
5Y CAGR
+16.5%/yr
Consistent
Acceleration
+13.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.18B | +10.6% |
| 2024 | $2.88B | +23.6% |
| 2023 | $2.33B | +20.2% |
| 2022 | $1.94B | +14.9% |
| 2021 | $1.69B | +13.6% |
| 2020 | $1.48B | +2.4% |
| 2019 | $1.45B | -11.0% |
| 2018 | $1.63B | -5.7% |
| 2017 | $1.73B | +7.9% |
| 2016 | $1.60B | - |